GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (NAS:AMPH) » Definitions » Shiller PE Ratio

Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Shiller PE Ratio : 59.58 (As of Apr. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Amphastar Pharmaceuticals Shiller PE Ratio?

As of today (2024-04-28), Amphastar Pharmaceuticals's current share price is $41.11. Amphastar Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 was $0.69. Amphastar Pharmaceuticals's Shiller PE Ratio for today is 59.58.

The historical rank and industry rank for Amphastar Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

AMPH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.35   Med: 62.99   Max: 114.2
Current: 59.77

During the past years, Amphastar Pharmaceuticals's highest Shiller PE Ratio was 114.20. The lowest was 14.35. And the median was 62.99.

AMPH's Shiller PE Ratio is ranked worse than
85.3% of 517 companies
in the Drug Manufacturers industry
Industry Median: 24.4 vs AMPH: 59.77

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Amphastar Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.680. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.69 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amphastar Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Amphastar Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Shiller PE Ratio Chart

Amphastar Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 46.40 89.92

Amphastar Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.40 59.96 103.80 70.52 89.92

Competitive Comparison of Amphastar Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amphastar Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Shiller PE Ratio falls into.



Amphastar Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amphastar Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=41.11/0.69
=59.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amphastar Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Amphastar Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.68/129.4194*129.4194
=0.680

Current CPI (Dec. 2023) = 129.4194.

Amphastar Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.037 99.695 -0.048
201406 -0.030 100.560 -0.039
201409 -0.120 100.428 -0.155
201412 -0.060 99.070 -0.078
201503 -0.010 99.621 -0.013
201506 -0.150 100.684 -0.193
201509 -0.070 100.392 -0.090
201512 0.170 99.792 0.220
201603 0.050 100.470 0.064
201606 0.150 101.688 0.191
201609 0.080 101.861 0.102
201612 -0.060 101.863 -0.076
201703 0.020 102.862 0.025
201706 0.040 103.349 0.050
201709 0.002 104.136 0.002
201712 0.030 104.011 0.037
201803 -0.150 105.290 -0.184
201806 -0.060 106.317 -0.073
201809 0.050 106.507 0.061
201812 0.040 105.998 0.049
201903 0.020 107.251 0.024
201906 0.960 108.070 1.150
201909 0.030 108.329 0.036
201912 -0.020 108.420 -0.024
202003 0.080 108.902 0.095
202006 -0.004 108.767 -0.005
202009 0.080 109.815 0.094
202012 -0.130 109.897 -0.153
202103 0.100 111.754 0.116
202106 0.160 114.631 0.181
202109 0.590 115.734 0.660
202112 0.390 117.630 0.429
202203 0.470 121.301 0.501
202206 0.330 125.017 0.342
202209 0.300 125.227 0.310
202212 0.660 125.222 0.682
202303 0.500 127.348 0.508
202306 0.490 128.729 0.493
202309 0.910 129.860 0.907
202312 0.680 129.419 0.680

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amphastar Pharmaceuticals  (NAS:AMPH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amphastar Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
11570 6th Street, Rancho Cucamonga, CA, USA, 91730
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Executives
Mary Z. Luo director, 10 percent owner, officer: COO and Chief Scientist 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Floyd F. Petersen director 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Rong Zhou officer: EVP, Production C/O AMPHASTAR PHARMACEUTICALS INC., 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Richard K Prins director
William J Peters officer: CFO, SVP & Treasurer C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Yakob Liawatidewi officer: SVP Corp Admin Center C/O AMPHASTAR PHARMACEUTICALS INC, 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Michael A Zasloff director
Gayle Deflin director 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Diane G. Gerst officer: EVP, QA & Regulatory Affairs 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Howard Lee director 13F-2, NO. 36, LANE 48, SECTION 3, NAN-JING EAST ROAD, TAIPEI, TAIWAN F4 00000
Jack Y. Zhang director, 10 percent owner, officer: CEO & Chief Scientific Officer 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
David Maris director C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Richard Koo director 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Jason B. Shandell director, officer: President 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Applied Physics & Chemistry Laboratories, Inc. 10 percent owner 13760 MAGNOLIA AVENUE, CHINO CA 91710